PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.\', \'VA Palo Alto Health Care System, Palo Alto, CA, USA.\', \'Biophysics Program, Stanford University, Stanford, CA, USA.\', \'Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. w.robinson@stanford.edu.\', \'VA Palo Alto Health Care System, Palo Alto, CA, USA. w.robinson@stanford.edu.\', \'Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. tlanz@stanford.edu.\', \'VA Palo Alto Health Care System, Palo Alto, CA, USA. tlanz@stanford.edu.\', \'Department of Neurology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. tlanz@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41590-021-01088-9
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 34848871
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
?:title
  • BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all